A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

Published:2015-09-16 Issue:2 Volume:22 Page:319-327
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Arai Sally,Pidala Joseph,Pusic Iskra,Chai Xiaoyu,Jaglowski Samantha,Khera Nandita,Palmer Jeanne,Chen George L.,Jagasia Madan H.,Mayer Sebastian A.,Wood William A.,Green Michael,Hyun Teresa S.,Inamoto Yoshihiro,Storer Barry E.,Miklos David B.,Shulman Howard M.,Martin Paul J.,Sarantopoulos Stefanie,Lee Stephanie J.,Flowers Mary E.D.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation;Blood Advances;2024-08-30

2. A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease;Journal of Clinical Oncology;2024-08-16

3. The Application of Umbilical Cord Blood-derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial;Transplantation and Cellular Therapy;2024-07

4. Long-Term Clinical Outcomes and B Cell Immune Reconstitution Following Allo-HCT With Prophylactic, Post-Transplant Rituximab;Transplantation and Cellular Therapy;2024-05

5. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development;Current Oncology;2024-03-08